Related Experiment Video
Updated: Feb 12, 2026

Focus Formation: A Cell-based Assay to Determine the Oncogenic Potential of a Gene
Published on: December 31, 2014
STAT3 as a potential immunotherapy biomarker in oncogene-addicted non-small cell lung cancer
Ilaria Attili1, Niki Karachaliou2, Laura Bonanno3
1Department of Surgery, Oncology and Gastroenterology, University of Padova, Via Giustiniani 2, 53, Padova 35128, Italy.
Abstract:
Immune checkpoint blockade has modified the treatment landscape for many types of tumors, including lung cancer. Still our knowledge on the biology of the interaction between tumor cells and the microenvironment is limited, preventing the optimal use of these new compounds and the maximum benefit that the patients can derive from them. We have actively worked on the role of STAT3, a transcriptional factor that causes innate resistance to targeted therapies in oncogene-addicted tumors. In this short review we take the opportunity to express our opinion and review existing knowledge on the immune role of STAT3 and the possible implications that this may have for the discovery of new biomarkers to predict response to immunotherapy, as well as new partners to combine with and increase the efficacy of immune checkpoint inhibitors.
Insights
STAT3 plays a key role in tumor resistance to therapies. Understanding its immune function could lead to new biomarkers and combination treatments for immune checkpoint inhibitors in lung cancer.
Area of Science:
- Oncology
- Immunology
- Molecular Biology
Background:
- Immune checkpoint blockade has revolutionized cancer treatment, particularly for lung cancer.
- Limited understanding of tumor-immune microenvironment interactions hinders optimal therapeutic benefit.
- STAT3 is implicated in innate resistance to targeted therapies in oncogene-driven tumors.
Discussion:
- This review explores the immune functions of STAT3.
- STAT3's role in innate resistance to targeted therapies is examined.
- The implications for predicting immunotherapy response are discussed.
Key Insights:
- STAT3's immune role is crucial for understanding treatment resistance.
- Identifying STAT3-related biomarkers may predict immunotherapy response.
- Targeting STAT3 pathways could enhance immunotherapy efficacy.
Outlook:
- Further research into STAT3's immune functions is warranted.
- Development of novel biomarkers for immunotherapy response prediction.
- Exploring combination strategies involving STAT3 inhibition and immune checkpoint inhibitors.
Related Concept Videos
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cell Potential and Free Energy
Thermodynamics is the branch of physics dealing with the relationship between heat and other forms of energy. In an electrochemical cell, chemical energy is converted into electrical energy.
Thus, a link can be predicted between cell potential, free energy change, and the equilibrium constant for the reaction. Cell potential can also be measured as the oxidant or the reducing strength, and similar acid-base strength measures are reflected in equilibrium...
Tumor Immunotherapy
Drug Abuse and Addiction: Pharmacological Phenomena
Lung Capacity
Potential Energy
Chemical bonds that form attractive forces between atoms also contain potential energy, called chemical energy. When a chemical reaction...

